衰弱对头颈癌手术后短期结局的影响
该横断面分析基于2001至2010年全国住院患者样本中159,301例因口腔、喉、下咽或口咽恶性肿瘤接受根治性手术的患者,采用交叉表和多因素回归分析。结果显示,衰弱与合并症、院内死亡、术后并发症、住院时间和费用独立相关,且与合并症对医疗并发症和住院时间存在协同交互作用。
要点
- 衰弱是头颈癌手术后死亡、并发症、住院时间和费用的独立预测因素。
- 衰弱患者术后急性医疗并发症风险显著增高(OR=3.9[3.2-4.9])。
- 衰弱与合并症对医疗并发症和住院时间存在协同交互作用。
核心结论
- 衰弱是头颈癌手术患者术后并发症、死亡、住院时间和费用的独立预测因素。
- 衰弱与合并症对急性医疗并发症和住院时间存在协同交互作用,同时衰弱且合并症患者医疗并发症和住院时间风险更高。
研究设计与样本
- 横断面分析,纳入2001至2010年全国住院患者样本中159,301例因口腔、喉、下咽或口咽恶性肿瘤接受根治性手术的患者。
- 衰弱定义基于约翰霍普金斯调整临床组衰弱定义诊断指标中的衰弱定义诊断集群。
主要发现
- 7.4%的患者被识别为衰弱。
- 衰弱与晚期合并症(OR=1.5[1.3-1.8])、医疗补助(OR=1.5[1.3-1.8])、大手术(OR=1.6[1.4-1.8])、皮瓣重建(OR=1.7[1.3-2.1])、高容量医院(OR=0.7[0.5-1.0])、出院至短期机构(OR=4.4[2.9-6.7])或其他机构(OR=5.4[4.5-6.6])显著相关。
- 衰弱显著预测院内死亡(OR=1.6[1.1-2.4])、术后外科并发症(OR=2.0[1.7-2.3])、急性医疗并发症(OR=3.9[3.2-4.9])、住院时间延长(平均4.9天)和平均增量费用增加(11,839美元)。
- 衰弱与合并症对急性医疗并发症和住院时间存在显著交互作用,同时衰弱且合并症患者医疗并发症和住院时间风险协同增加。
- 衰弱与外科并发症和费用增加的关联强度高于晚期合并症。
临床怎么用
- 在头颈癌手术患者术前评估中应识别衰弱状态,以预测术后短期不良结局和资源使用。
- 对同时存在衰弱和合并症的患者,应加强术后医疗并发症监测和住院时间管理。
局限性
- 研究为横断面分析,仅能提示关联而非因果。
- 数据来源于2001至2010年全国住院患者样本,时效性有限。
- 衰弱定义基于行政数据库中的诊断集群,可能存在错分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the relationship between frailty and comorbidity, in-hospital mortality, postoperative complications, length of hospital stay (LOS), and costs in head and neck cancer (HNCA) surgery. STUDY DESIGN: Cross-sectional analysis. METHODS: Discharge data from the Nationwide Inpatient Sample for 159,301 patients who underwent ablative surgery for a malignant oral cavity, laryngeal, hypopharyngeal, or oropharyngeal neoplasm in 2001 to 2010 was analyzed using cross-tabulations and multivariate regression modeling. Frailty was defined based on frailty-defining diagnosis clusters from the Johns Hopkins Adjusted Clinical Groups frailty-defining diagnosis indicator. RESULTS: Frailty was identified in 7.4% of patients and was significantly associated with advanced comorbidity (odds ratio [OR] = 1.5[1.3-1.8]), Medicaid (OR = 1.5[1.3-1.8]), major procedures (OR = 1.6[1.4-1.8]), flap reconstruction (OR = 1.7[1.3-2.1]), high-volume hospitals (OR = 0.7[0.5-1.0]), discharge to a short-term facility (OR = 4.4[2.9-6.7]), or other facility (OR = 5.4[4.5-6.6]). Frailty was a significant predictor of in-hospital death (OR = 1.6[1.1-2.4]), postoperative surgical complications (OR = 2.0[1.7-2.3]), acute medical complications (OR = 3.9[3.2-4.9]), increased LOS (mean, 4.9 days), and increased mean incremental costs ($11,839), and was associated with higher odds of surgical complications and increased costs than advanced comorbidity. There was a significant interaction between frailty and comorbidity for acute medical complications and length of hospitalization, with a synergistic effect on the odds of medical complications and LOS in patients with comorbidity who were also frail. CONCLUSION: Frailty is an independent predictor of postoperative morbidity, mortality, LOS, and costs in HNCA surgery patients, and has a synergistic interaction with comorbidity that is associated with an increased likelihood of medical complications and greater LOS in patients with comorbidity who are also frail. LEVEL OF EVIDENCE: 2c. Laryngoscope, 128:102-110, 2018.
引用
- Nieman CL, Pitman KT, Tufaro AP, et al. The effect of frailty on short-term outcomes after head and neck cancer surgery. Laryngoscope. 2017. PMID: 28731497. doi:10.1002/lary.26735
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。